Filing Flows › DataMeds AI (MEDS) › Q2 2026 › vs Q1 2026
DataMeds AI (MEDS) Q2 2026 vs Q1 2026 (quarter over quarter)
DataMeds AI's revenue rose $220K (+14%) from $1.6M in Q1 2026 to $1.8M in Q2 2026.
DataMeds AI, Q2 2026: revenue $1.8M (-77% year over year), operating margin -412.7%, net loss $18.4M, operating cash flow −$2.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8M | $1.6M | $220K | +14% |
| Net loss | $18.4M | $7.7M | $10.6M | +137% |
| Costs & expenses | $20.1M | $9.3M | $10.8M | +117% |
| Operating costs | $9.1M | $7.6M | $1.5M | +20% |
| Interest & other, net | $11.0M | $1.7M | $9.3M | +538% |
| Cost of revenue | $1.6M | $1.4M | $208K | +15% |
| Sales & marketing | $114K | $960K | −$846K | -88% |
| General & admin | $7.1M | $4.9M | $2.2M | +45% |
| Other operating costs | $357K | $357K | −$227 | -0.1% |
| Operating cash sources | $18.4M | $7.7M | $10.6M | +137% |
| Depreciation & amortization | $357K | $357K | −$227 | -0.1% |
| Share-based compensation | $1.2M | $1.4M | −$153K | -11% |
| Working capital & other | $13.9M | $2.6M | $11.3M | +432% |
| Cash used in operations | $2.9M | $3.4M | −$519K | -15% |
| Net loss absorbed | $18.4M | $7.7M | $10.6M | +137% |
Questions
How much did DataMeds AI's revenue grow quarter over quarter in Q2 2026?
DataMeds AI's revenue rose $220K (+14%) from $1.6M in Q1 2026 to $1.8M in Q2 2026.